CNS vs RILYG

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CNS

59.9
AI Score
VS
RILYG Wins

RILYG

63.7
AI Score

Investment Advisor Scores

CNS

Oct 02, 2026
60score
Recommendation
HOLD

RILYG

Oct 02, 2026
64score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CNS RILYG Winner
Forward P/E 18.4502 0 Tie
PEG Ratio 1.6881 0 Tie
Revenue Growth 12.2% 0.0% CNS
Earnings Growth 31.9% 0.0% CNS
Tradestie Score 59.9/100 63.7/100 RILYG
Profit Margin 28.8% 0.0% CNS
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CNS 1M: -5.6% · 3M: -6.9% RILYG 1M: +0.1% · 3M: +1.5%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 36

RSI (14): 36.2 · Price: $73.12

RILYG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 57

RSI (14): 57.1 · Price: $24.79

Fundamentals Snapshot

Metric CNS RILYG
Market Cap — —
Forward P/E 18.4 0.0
Trailing P/E 22.4 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% —
Operating Margin 0.3% 0.0%
EPS 3.26 0.00
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, RILYG is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.